COLISTIMETHATE (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
APP PHARMACEUTI
Indication
Enterobacter infection
An Enterobacter infection is an opportunistic bacterial disease caused by members of the genus *Enterobacter*, most notably the *Enterobacter cloacae* complex, which are facultatively anaerobic, Gram-negative bacilli. Read more about Enterobacter infection
14 drugs 13 manufacturers
Drugs that treat it
Common Enterobacter infection therapies.
COLY-MYCIN M PARENTERAL (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
JHP PHARMACEUTI
COLISTIMETHATE SODIUM (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
PADDOCK LABS.
COLISTIMETHATE (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
JHP PHARMACEUTI
COLISTIMETHATE (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
HERITAGE PHARMA
COLISTIMETHATE (colistin (as colistimethate sodium))
POLYMYXINS·KLEBSIELLA INFECTION·+3
PAR HEALTH USA,
COLY-MYCIN M PARENTERAL (colistin (as colistimethate sodium))
POLYMYXINS·KLEBSIELLA INFECTION·+3
PAR HEALTH USA,
COLISTIMETHATE (colistin (as colistimethate sodium))
KLEBSIELLA INFECTION·+3
PERRIGO CO.
COLISTIMETHATE (colistin (as colistimethate sodium))
POLYMYXINS·KLEBSIELLA INFECTION·+3
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Enterobacter infection preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn Enterobacter infection is an opportunistic bacterial disease caused by members of the genus *Enterobacter*, most notably the *Enterobacter cloacae* complex, which are facultatively anaerobic, Gram-negative bacilli.
Commonly encountered as healthcare-associated pathogens, these organisms primarily affect hospitalized, critically ill, or immunocompromised individuals, frequently involving patients with indwelling devices, central venous catheters, or endotracheal tubes.
Manifestations span multiple organ systems, resulting in catheter-associated urinary tract infections, ventilator-associated pneumonia, surgical site and intra-abdominal infections, and bacteremia or sepsis.
A defining pathophysiologic feature is the pathogen's capacity for multidrug resistance, driven predominantly by inducible chromosomal AmpC beta-lactamases and the potential acquisition of extended-spectrum beta-lactamases or carbapenemases.
- nih.gov
An Enterobacter infection is an opportunistic bacterial disease caused by members of the genus *Enterobacter*, most notably the *Enterobacter cloacae* complex, which are facultatively anaerobic, Gram-negative bacilli Commonly encountered as healthcare-associated pathogens, these organisms primarily affect hospitalized, critically ill, or immunocompromised individuals, frequently involving patients with indwelling devices, central venous catheters, or endotracheal tubes A defining pathophysiologi...
- canada.ca
An Enterobacter infection is an opportunistic bacterial disease caused by members of the genus *Enterobacter*, most notably the *Enterobacter cloacae* complex, which are facultatively anaerobic, Gram-negative bacilli Manifestations span multiple organ systems, resulting in catheter-associated urinary tract infections, ventilator-associated pneumonia, surgical site and intra-abdominal infections, and bacteremia or sepsis
- nih.gov
Manifestations span multiple organ systems, resulting in catheter-associated urinary tract infections, ventilator-associated pneumonia, surgical site and intra-abdominal infections, and bacteremia or sepsis
Personalize your experience
Follow Enterobacter infection and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.